166 related articles for article (PubMed ID: 31744350)
21. US-guided microwave ablation for primary hyperparathyroidism: a safety and efficacy study.
Fan BQ; He XW; Chen HH; Zhang WM; Tang W
Eur Radiol; 2019 Oct; 29(10):5607-5616. PubMed ID: 30888479
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Persistent Hyperparathyroidism After Renal Transplantation.
Yamamoto T; Tominaga Y; Okada M; Hiramitsu T; Tsujita M; Goto N; Narumi S; Watarai Y
World J Surg; 2016 Mar; 40(3):600-6. PubMed ID: 26546189
[TBL] [Abstract][Full Text] [Related]
23. A short-term non-randomized controlled study of ultrasound-guided microwave ablation and parathyroidectomy for secondary hyperparathyroidism.
Zhao J; Qian L; Teng C; Yu M; Liu F; Liu Y; Tan X; Li J
Int J Hyperthermia; 2021; 38(1):1558-1565. PubMed ID: 34724860
[TBL] [Abstract][Full Text] [Related]
24. Radiofrequency ablation for patients with recurrent or persistent secondary hyperparathyroidism after parathyroidectomy: initial experience.
Jiang T; Deng E; Chai H; Weng N; He H; Zhang Z; Li D; Yue W; Peng C; Xu HX
Endocrine; 2024 Mar; 83(3):681-690. PubMed ID: 37725290
[TBL] [Abstract][Full Text] [Related]
25. Risk Factors of Severe Hypocalcemia After US-Guided Percutaneous Microwave Ablation of the Parathyroid Gland in Patients with Secondary Hyperparathyroidism.
Wei Y; Peng LL; Zhao ZL; Li Y; Yu MA
J Bone Miner Res; 2020 Apr; 35(4):691-697. PubMed ID: 31821603
[TBL] [Abstract][Full Text] [Related]
26. Preliminary report of microwave ablation for the primary papillary thyroid microcarcinoma: a large-cohort of 185 patients feasibility study.
Teng DK; Li HQ; Sui GQ; Lin YQ; Luo Q; Fu P; Du JR; Jin CX; Wang H
Endocrine; 2019 Apr; 64(1):109-117. PubMed ID: 30771153
[TBL] [Abstract][Full Text] [Related]
27. US-Guided Percutaneous Microwave Ablation for Primary Hyperparathyroidism with Parathyroid Nodules: Feasibility and Safety Study.
Liu C; Wu B; Huang P; Ding Q; Xiao L; Zhang M; Zhou J
J Vasc Interv Radiol; 2016 Jun; 27(6):867-75. PubMed ID: 27106734
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of efficacy of ultrasound-guided microwave ablation in primary hyperparathyroidism.
Zhang M; Gao Y; Zhang X; Ding Z; Wang X; Jiang W; Zhao C
J Clin Ultrasound; 2022 Feb; 50(2):227-235. PubMed ID: 34984687
[TBL] [Abstract][Full Text] [Related]
29. Microwave ablation as an efficient therapy for primary hyperparathyroidism: Efficacy and predictors of treatment success.
Erturk MS; Cekic B; Sarı IK; Pamuk BO
Int J Clin Pract; 2021 Oct; 75(10):e14580. PubMed ID: 34185346
[TBL] [Abstract][Full Text] [Related]
30. Comparison of ultrasound-guided percutaneous microwave ablation and parathyroidectomy for primary hyperparathyroidism.
Liu F; Yu X; Liu Z; Qiao Z; Dou J; Cheng Z; Han Z; Yu J; Liang P
Int J Hyperthermia; 2019; 36(1):835-840. PubMed ID: 31452422
[No Abstract] [Full Text] [Related]
31. [Effectiveness and safety of ultrasound-guided microwave ablation for the treatment of primary hyperparathyroidism in 12 patients with parathyroid adenoma].
Ni WJ; Chu XQ; Lu CY; Chen GF; Han X; Xu Y; Wu XP; Wang JH; Liu C; Xu SH
Zhonghua Nei Ke Za Zhi; 2021 Oct; 60(10):904-907. PubMed ID: 34551480
[TBL] [Abstract][Full Text] [Related]
32. Two-year changes of biochemical profiles and bone mineral density after percutaneous ultrasound-guided microwave ablation for primary hyperparathyroidism.
Wu W; Zhou Q; Xu S; An S; Shen F; Li H; Gong X; Chen X
Endocrine; 2021 Feb; 71(2):476-483. PubMed ID: 33025562
[TBL] [Abstract][Full Text] [Related]
33. Contrast-enhanced ultrasound-guided percutaneous microwave ablation of renal cell carcinoma that is inconspicuous on conventional ultrasound.
Chen CN; Liang P; Yu J; Yu XL; Cheng ZG; Han ZY; Liu FY; Li X
Int J Hyperthermia; 2016 Sep; 32(6):607-13. PubMed ID: 27269816
[TBL] [Abstract][Full Text] [Related]
34. Microwave ablation versus radiofrequency ablation for primary hyperparathyroidism: a multicenter retrospective study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Chai HH; Yu MA
Int J Hyperthermia; 2021; 38(1):1023-1030. PubMed ID: 34219596
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and Safety of Thermal Ablation in the Treatment of Primary Hyperparathyroidism: A Multicenter Study.
Wei Y; Peng CZ; Wang SR; He JF; Peng LL; Zhao ZL; Cao XJ; Li Y; Yu MA
J Clin Endocrinol Metab; 2021 Aug; 106(9):2707-2717. PubMed ID: 33846740
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Microwave Ablation Versus Cryoablation in the Treatment of T1a Renal Tumors.
De Cobelli F; Papa M; Panzeri M; Colombo M; Steidler S; Ambrosi A; Cao R; Gusmini S; Marra P; Capitanio U; Bertini R; Venturini M; Losa A; Gaboardi F; Montorsi F; Cardone G
Cardiovasc Intervent Radiol; 2020 Jan; 43(1):76-83. PubMed ID: 31451888
[TBL] [Abstract][Full Text] [Related]
37. Ultrasound-guided hydrodissection for assisting percutaneous microwave ablation of renal cell carcinomas adjacent to intestinal tracts: a preliminary clinical study.
Cheng Z; Yu X; Han Z; Liu F; Yu J; Liang P
Int J Hyperthermia; 2018 May; 34(3):315-320. PubMed ID: 28641464
[TBL] [Abstract][Full Text] [Related]
38. Complications encountered in the treatment of primary and secondary hyperparathyroidism with microwave ablation - a retrospective study.
Wei Y; Peng LL; Zhao ZL; Li Y; Yu MA
Int J Hyperthermia; 2019; 36(1):1264-1271. PubMed ID: 31818158
[No Abstract] [Full Text] [Related]
39. Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study.
Diao Z; Qian L; Teng C; Zhang N; Liang J; Kong L; Li H; Tian C; Liu W
Int J Hyperthermia; 2021; 38(1):213-219. PubMed ID: 33593216
[TBL] [Abstract][Full Text] [Related]
40. Hypocalcemia after ultrasound-guided microwave ablation and total parathyroidectomy for secondary hyperparathyroidism: a retrospective study.
Wei Y; Yu MA; Qian LX; Zhao ZL; Cao XJ; Peng LL; Li Y
Int J Hyperthermia; 2020; 37(1):819-825. PubMed ID: 32633649
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
